The prognostic role of the CHA₂DS₂-VASc score in patients with acute myocardial infarction receiving extracorporeal membrane oxygenation following out-of-hospital cardiac arrest
Open Access
- 23 March 2025
- journal article
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 6 (2) , 116-123
Abstract
Aims: The CHA₂DS₂-VASc scoring system has been widely used for stroke risk stratification in patients with atrial fibrillation, yet evidence regarding its prognostic value in other critical settings remains limited. This study aimed to assess the utility of the CHA₂DS₂-VASc score in predicting mortality in patients with acute myocardial infarction (AMI) who received veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support following out-of-hospital cardiac arrest. Methods: This retrospective study included 41 patients with AMI requiring VA-ECMO after OHCA. Baseline demographics, clinical characteristics, and prognostic scores, including CHA₂DS₂-VASc, SAVE (Survival After Veno-Arterial ECMO), Glasgow Coma Scale (GCS), and acute physiology and chronic health evaluation (APACHE) II were recorded. Patients were categorized into three risk groups based on the CHA₂DS₂-VASc score: low (0 points), moderate (1 point), and high (≥2 points). According to the SAVE score, patients were classified into five risk groups: class I (≥5 points), class II (1–4 points), class III (−4 to 0 points), class IV (−9 to −5 points), and class V (≤−10 points). The primary outcome was in-hospital mortality. Results: The overall in-hospital mortality rate was 58.5%. Patients with high risk group had a significantly higher mortality risk (HR: 3.12, 95% CI: 1.28-7.63, p=0.008). The SAVE score had the highest diagnostic performance, with a sensitivity of 81.2% and specificity of 76.5% (AUC=0.80). CHA₂DS₂-VASc (AUC=0.74) and APACHE II (AUC=0.72) also demonstrated good predictive performance. While CHA₂DS₂-VASc maintained a balanced sensitivity (70.8%) and specificity (64.7%), APACHE II had higher sensitivity (75.7%) but lower specificity (58.8%). GCS demonstrated the lowest diagnostic performance (AUC=0.68). Conclusion: While the SAVE score, a risk model specifically designed for VA-ECMO, provides a strong prognostic evaluation, the CHA₂DS₂-VASc score could be a simple and easily applicable tool for early risk stratification in this high-risk population.Keywords
This publication has 44 references indexed in Scilit:
- Prognostic factors associated with favourable functional outcome among adult patients requiring extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest: A systematic review and meta-analysisResuscitation, 2023
- Prognostic performance of CHA₂DS₂-VASc scores for predicting mortality among COVID-19 patients: A single pandemic center experienceThe American Journal of Emergency Medicine, 2021
- Admission blood glucose level and outcome in patients requiring venoarterial extracorporeal membrane oxygenationClinical Research in Cardiology, 2021
- European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstancesResuscitation, 2021
- Predicting Survival After VA-ECMO for Refractory Cardiogenic Shock: Validating the SAVE ScoreCJC Open, 2021
- Pre-arrest and intra-arrest prognostic factors associated with survival following traumatic out-of-hospital cardiac arrest – A systematic review and meta-analysisResuscitation, 2020
- Acute Heart Failure: Definition, Classification and EpidemiologyCurrent Heart Failure Reports, 2017
- The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shockIntensive Care Medicine, 2016
- The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndromeIntensive Care Medicine, 2013
- Prognostic indicators and outcome prediction model for patients with return of spontaneous circulation from cardiopulmonary arrest: The Utstein Osaka ProjectResuscitation, 2011